Literature DB >> 33350962

The Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study.

Susie Cartledge1,2, Ralph Maddison2, Sara Vogrin3, Roman Falls3, Odgerel Tumur3, Ingrid Hopper4, Christopher Neil3,5.   

Abstract

BACKGROUND: Heart failure decompensation is a major driver of hospitalizations and represents a significant burden to the health care system. Identifying those at greatest risk of admission can allow for targeted interventions to reduce this risk.
OBJECTIVE: This paper aims to compare the predictive value of objective and subjective heart failure respiratory symptoms on imminent heart failure decompensation and subsequent hospitalization within a 30-day period.
METHODS: A prospective observational pilot study was conducted. People living at home with heart failure were recruited from a single-center heart failure outpatient clinic. Objective (blood pressure, heart rate, weight, B-type natriuretic peptide) and subjective (4 heart failure respiratory symptoms scored for severity on a 5-point Likert scale) data were collected twice weekly for a 30-day period.
RESULTS: A total of 29 participants (median age 79 years; 18/29, 62% men) completed the study. During the study period, 10 of the 29 participants (34%) were hospitalized as a result of heart failure. For objective data, only heart rate exhibited a between-group difference. However, it was nonsignificant for variability (P=.71). Subjective symptom scores provided better prediction. Specifically, the highest precision of heart failure hospitalization was observed when patients with heart failure experienced severe dyspnea, orthopnea, and bendopnea on any given day (area under the curve of 0.77; sensitivity of 83%; specificity of 73%).
CONCLUSIONS: The use of subjective respiratory symptom reporting on a 5-point Likert scale may facilitate a simple and low-cost method of predicting heart failure decompensation and imminent hospitalization. Serial collection of symptom data could be augmented using ecological momentary assessment of self-reported symptoms within a mobile health monitoring strategy for patients at high risk for heart failure decompensation. ©Susie Cartledge, Ralph Maddison, Sara Vogrin, Roman Falls, Odgerel Tumur, Ingrid Hopper, Christopher Neil. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 22.12.2020.

Entities:  

Keywords:  cardiac failure; heart failure; hospitalization; mHealth; readmission; risk prediction

Mesh:

Year:  2020        PMID: 33350962      PMCID: PMC7785406          DOI: 10.2196/18496

Source DB:  PubMed          Journal:  JMIR Mhealth Uhealth        ISSN: 2291-5222            Impact factor:   4.773


  17 in total

1.  A development and evaluation process for mHealth interventions: examples from New Zealand.

Authors:  Robyn Whittaker; Sally Merry; Enid Dorey; Ralph Maddison
Journal:  J Health Commun       Date:  2012

2.  Roles of nonclinical and clinical data in prediction of 30-day rehospitalization or death among heart failure patients.

Authors:  Quan L Huynh; Makoto Saito; Christopher L Blizzard; Mehdi Eskandari; Ben Johnson; Golsa Adabi; Joshua Hawson; Kazuaki Negishi; Thomas H Marwick
Journal:  J Card Fail       Date:  2015-02-24       Impact factor: 5.712

3.  An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure.

Authors:  Patricia S Keenan; Sharon-Lise T Normand; Zhenqiu Lin; Elizabeth E Drye; Kanchana R Bhat; Joseph S Ross; Jeremiah D Schuur; Brett D Stauffer; Susannah M Bernheim; Andrew J Epstein; Yongfei Wang; Jeph Herrin; Jersey Chen; Jessica J Federer; Jennifer A Mattera; Yun Wang; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-09

4.  National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018.

Authors:  John J Atherton; Andrew Sindone; Carmine G De Pasquale; Andrea Driscoll; Peter S MacDonald; Ingrid Hopper; Peter M Kistler; Tom Briffa; James Wong; Walter Abhayaratna; Liza Thomas; Ralph Audehm; Phillip Newton; Joan O'Loughlin; Maree Branagan; Cia Connell
Journal:  Heart Lung Circ       Date:  2018-10       Impact factor: 2.975

5.  An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients.

Authors:  K J Carlson; D C Lee; A H Goroll; M Leahy; R A Johnson
Journal:  J Chronic Dis       Date:  1985

6.  Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure.

Authors:  Amir Solomonica; Andrew J Burger; Doron Aronson
Journal:  Circ Heart Fail       Date:  2012-11-14       Impact factor: 8.790

7.  Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.

Authors:  Justin M Vader; Shane J LaRue; Susanna R Stevens; Robert J Mentz; Adam D DeVore; Anuradha Lala; John D Groarke; Omar F AbouEzzeddine; Shannon M Dunlay; Justin L Grodin; Victor G Dávila-Román; Lisa de Las Fuentes
Journal:  J Card Fail       Date:  2016-04-28       Impact factor: 5.712

Review 8.  Statistical models and patient predictors of readmission for heart failure: a systematic review.

Authors:  Joseph S Ross; Gregory K Mulvey; Brett Stauffer; Vishnu Patlolla; Susannah M Bernheim; Patricia S Keenan; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2008-07-14

9.  Review and Analysis of Existing Mobile Phone Apps to Support Heart Failure Symptom Monitoring and Self-Care Management Using the Mobile Application Rating Scale (MARS).

Authors:  Ruth M Masterson Creber; Mathew S Maurer; Meghan Reading; Grenny Hiraldo; Kathleen T Hickey; Sarah Iribarren
Journal:  JMIR Mhealth Uhealth       Date:  2016-06-14       Impact factor: 4.773

Review 10.  Risk prediction in patients with heart failure: a systematic review and analysis.

Authors:  Kazem Rahimi; Derrick Bennett; Nathalie Conrad; Timothy M Williams; Joyee Basu; Jeremy Dwight; Mark Woodward; Anushka Patel; John McMurray; Stephen MacMahon
Journal:  JACC Heart Fail       Date:  2014-09-03       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.